Ntla stock forecast.

Shares of Intellia Therapeutics, Inc. (NTLA) have gained 23.5% over the past four weeks to close the last trading session at $43.19, but there could still be a solid upside left in the stock if ...Nov 3, 2023 · Intellia Therapeutics Stock Forecast 2023. In the last five quarters, Intellia Therapeutics’s Price Target has risen from $0.00 to $25.05 - a 100% increase. Three analysts predict that Intellia Therapeutics’s share price will increase in the coming year, reaching $72.00. This would represent an increase of 187.43%. Analysts have provided the following ratings for Intellia Therapeutics (NASDAQ:NTLA) within the last quarter: These 9 analysts have an average price target of $70.78 versus the current price of ...NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.

The Intellia Therapeutics stock forecast for tomorrow is $ 30.29, which would represent a -1.78% loss compared to the current price. In the next week, the price of NTLA is expected to increase by 11.80% and hit $ 34.48.. As far as the long-term Intellia Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.

Nov 29, 2023 · Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.

Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...November 14, 2025 Intellia Therapeutics Company Overview – November 2023. June 12, 2023 NTLA-2002 Interim Clinical Update – June 12, 2023. November 14, 2022 NTLA-2002 Interim Clinical Data Update – November 14, 2022. September 16, 2022 In vivo CRISPR/Cas9 editing of KLKB1 in patients with HAE – September 16, 2022.The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +137.08% increase from the last price of 30.37. The current consensus among 27 polled investment analysts is to Buy stock in Intellia ...

(See NTLA stock forecast)Pacific Biosciences (PACB)We’ll stay in the biotech space for the next Wood-backed name, although Pacific Biosciences operates in a different segment.

The Intellia Therapeutics Inc stock price gained 2.54% on the last trading day (Friday, 24th Nov 2023), rising from $30.26 to $31.03. During the last trading day the stock fluctuated 5.87% from a day low at $30.13 to a day high of $31.90. The price has risen in 6 of the last 10 days and is up by 24.32% over the past 2 weeks.

Mar 3, 2022 · Intellia Therapeutics. Market Cap. $3B. Today's Change. (-1.23%) -$0.38. Current Price. $30.65. Price as of November 27, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may ... Intellia Therapeutics Inc (NTLA) Stock Price & News - Google Finance Home NTLA • NASDAQ Intellia Therapeutics Inc Follow Share $30.93 After Hours: $31.14 (0.68%) +0.21 Closed: Nov 29, 5:10:43... As of July 20, 2023, 4:00 PM CST, Intellia Therapeutics Inc’s stock price was $43.28. Intellia Therapeutics Inc is down 5.13% from its previous closing price of $45.62. During the last market session, Intellia Therapeutics Inc’s stock traded between $44.60 and $46.00. Currently, there are 87.77 million shares of Intellia Therapeutics Inc ...See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Stock Price Forecast. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +175.23% increase from the …

According to 11 Wall Street analyst s that have issued a 1 year NTLA price target, the average NTLA price target is $77.46, with the highest NTLA stock price forecast at …The latest Intellia Therapeutics stock prices, stock quotes, news, and NTLA history to help you invest and trade smarter. ... The 61 analysts offering price forecasts for Intellia Therapeutics ... Teladoc Health Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 17.85. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.410%. Pessimistic target level: 17.63. Optimistic target level: 18.06.12/01/2023. Nvidia stock price stood at $467.65. According to the latest long-term forecast, Nvidia price will hit $500 by the end of 2023 and then $600 by the end of 2024. Nvidia will rise to $900 within the year of 2025, $1100 in 2026, $1200 in 2027, $1400 in 2028, $1500 in 2029, $1600 in 2030, $1700 in 2031, $1800 in 2033 and $2000 in 2035.There was a snowstorm in the Northeast this week. Or maybe that supposed storm was just a light dusting. It depends on who you ask. Having grown up in the mountains of Colorado, I am well aware at just how terrible these forecasts tend to b...Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s ( NTLA) price is currently up 15.63% so far this month. During the month of May, Intellia Therapeutics Inc’s stock price has reached a high of $44.21 and a low of $36.89. Over the last year, Intellia Therapeutics Inc has hit prices as high as $76.45 and as low as $32.44.

Bionano Genomics Inc () Stock Market info Recommendations: Buy or sell Bionano Genomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below.According to present data Bionano Genomics's BNGO shares and potentially its …About. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...

The Vanguard Group, Inc. is the second largest shareholder owning 9.2% of common stock, and BlackRock, Inc. holds about 9.1% of the company stock. Furthermore, CEO John Leonard is the owner of 0.9 ...(See NTLA stock forecast on TipRanks) PDS Biotechnology . The next stock on Oppenheimer's radar is another biopharma company, PDS Biotechnology. PDS has a research program focuses on immuno ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ... Blair reiterated a Buy rating for NTLA stock.All in all, Wall Street has a Strong Buy consensus rating for NTLA stock, with 15 Buys and three Holds. At $102.11, the average NTLA stock price target ...2014. 598. John Leonard. https://www.intelliatx.com. Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company’s in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary ...Intellia Therapeutics Stock Chart and Share Price Forecast, Short-Term "NTLA" Stock Prediction for Next Days and Weeks Walletinvestor.com Intellia Therapeutics Inc (NTLA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024The average Marvell Technology stock price prediction forecasts a potential upside of 25.7% from the current MRVL share price of $56.03. What is MRVL's forecast return on equity (ROE) for 2024-2026? (NASDAQ: MRVL) forecast ROE is …A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Dosed first patient in the global Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE)Expects to complete enrollment in the Phase 2 study of NTLA-2002 in 2H 2023Plans to ...

Jun 13, 2023 · Intellia's Q1 2023 financial report shows a cash position of $1.2 billion, with collaboration revenue rising to $12.6 million and a net loss of $103.1 million. The success of NTLA-2002 in further ...

Stocks making the biggest moves midday: Tesla, Disney, Alibaba, Ulta Beauty and more. Published Fri, Dec 1 202312:20 PM EST. Samantha Subin …The stock is selling for $100.49, and its $155.67 average price target is almost identical to Nowinski’s objective. (See Zscaler stock forecast ) Intellia Therapeutics ( NTLA )Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAs of March 29, 2023, 4:00 PM CST, Intellia Therapeutics Inc’s stock price was $37.56. Intellia Therapeutics Inc is up 4.28% from its previous closing price of $36.02. During the last market session, Intellia Therapeutics Inc’s stock traded between $35.98 and $37.55. Currently, there are 81.26 million shares of Intellia Therapeutics Inc ...Aug 3, 2023 · Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.40 per share versus the Zacks Consensus Estimate of a loss of $1.32. This compares to loss of $1.33 per share a year ago. View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time …Intellia Therapeutics ( NTLA -3.53%) works in the up-and-coming area of gene editing. Invitae ( NVTA 0.75%) specializes in genetic testing. Both stocks have declined over the past year. But Wall ...0.00%. $1.55M. NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00.Cathie Wood and Wall Street analysts aren't always on the same page. Analysts are bearish, for example, on the three stocks that have helped the most in Wood's Ark Innovation ETF (ARKK 1.26% ...

The stock market has always been a volatile environment – but the last several weeks have seen an increase in that phenomenon. The bull market of 2021 shifted into reverse in January, and increased intraday swings, along with a partial reversal of losses, have been the order of the day in February. Unsurprisingly, much of the market’s …Gene editing stocks, led by NTLA stock, ... And for 2028, analysts forecast the sector to bring in revenue of $62.9 billion. Bionano Genomics’ flagship product is Saphyr, ...Jun 28, 2021 · Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics. ... And for 2028, analysts forecast the sector to bring in revenue ... Instagram:https://instagram. uranium mining stocksvanguard esg us stock etftoon stocktwitslenovo competitors NTLA is a biotech company that develops gene editing therapies for cancer and other diseases. The average price target for its stock is $82.19, with a range of $40 to $144, based on 21 analyst recommendations. The stock has a strong buy rating from 18 brokerage firms and a low of 40.00. The upside is 237.12%. annuities best ratesrobinhood margin interest rate That revenue goes along with positive earnings per share of $12.83 in 2022. And the forecast is that Vertex will grow earnings in 2023. ... Analysts are bullish on NTLA stock. It currently has a ...Analysts have provided the following ratings for Intellia Therapeutics (NASDAQ:NTLA) within the last quarter: These 9 analysts have an average price target of $70.78 versus the current price of ... jepi september 2023 dividend If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.